Catalyst
Slingshot members are tracking this event:
Advisory Committee Meeting on Karyopharm's (KPTI) Selinexor in Quadruple Refractory Multiple Myeloma expected February 26, 2019. Briefing notes likely out February 22.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KPTI | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 26, 2019
Occurred Source:
https://investors.karyopharm.com/news-releases/news-release-details/karyopharm-announces-outcome-fda-advisory-committee-meeting
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Selinexor, Quadruple Refractory Multiple Myeloma, Ad-comm
